International Stem Cell (ISCO) Price to Sales (2010 - 2026)

International Stem Cell (ISCO) has reported Price to Sales for 17 consecutive years, with 0.57 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Price to Sales rose 8.63% year-over-year to 0.57 in Q2 2026; TTM through Jun 2026 was 0.16, a 13.27% increase from a year earlier, with the FY2025 full-year figure at 0.12, up 74.71% from the prior year.
• Price to Sales was 0.57 for Q2 2026 at International Stem Cell, up from 0.52 in the prior quarter.
• Over five years, Price to Sales peaked at 1.9 in Q1 2022 and troughed at 0.21 in Q2 2024.
• A 5-year average of 0.67 and a median of 0.52 in 2025 frame the typical range for Price to Sales.
• Across the five-year window, Price to Sales tumbled 72.01% in 2023 and soared 154.03% in 2025, its largest moves.
• Over 5 years, Price to Sales stood at 0.59 in 2022, then tumbled by 57.12% to 0.25 in 2023, then grew by 2.97% to 0.26 in 2024, then jumped by 98.63% to 0.52 in 2025, then increased by 9.33% to 0.57 in 2026.
• The last three Price to Sales figures came in at 0.57 (Q2 2026), 0.52 (Q4 2025), and 0.44 (Q3 2025), per Business Quant data.